Douwe Ekke Atsma

Douwe Ekke Atsma

Auto-generated profile, based on publicly available information

Douwe Ekke Atsma

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2009 in JAMA
Verified
Journal Article
Closed access
PDF file
JRJan van Ramshorst
Jan van Ramshorst
JBJeroen J. Bax
Jeroen J. Bax
SBSaskia L. M. A. Beeres
Saskia L. M. A. Beeres
PDPetra Dibbets-Schneider
Petra Dibbets-Schneider
SRStijntje D. Roes
Stijntje D. Roes
DADouwe E. Atsma
Douwe E. Atsma
Research from JAMA — Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia — A Randomized Controlled Trial

21 September 2006 in Stem Cells
Verified
Journal Article
Open access
PDF file
JTJohn van Tuyn
John van Tuyn
DADouwe E. Atsma
Douwe E. Atsma
EWElizabeth M. Winter
Elizabeth M. Winter
IDIetje van der Velde-Van Dijke
Ietje van der Velde-Van Dijke
DPDaniel A. Pijnappels
Daniel A. Pijnappels
AVAntoine A.F. de Vries
Antoine A.F. de Vries
Myocardial and coronary development are both critically dependent on epicardial cells. During cardiomorphogenesis, a subset of epicardial cells undergoes an epithelial-to-mesenchymal transition (EMT) and invades the myocardium to differentiate into various cell types, including coronary smooth muscle cells and perivascular and cardiac interstitial fibroblasts. Our current knowledge of epicardial EMT and the ensuing epicardium-derived cells (EPDCs) comes primarily from studies of chick and mouse embryonic development. Due to the absence of an in vitro culture system, very little is known about human EPDCs. Here, we report for the first time the establishment of cultures of primary epicardial cells from human adults and describe their immunophenotype, transcriptome, transducibility, and differentiation potential in vitro. Changes in morphology and β-catenin staining pattern indicated that human epicardial cells spontaneously undergo EMT early during ex vivo culture. The surface antigen profile of the cells after EMT closely resembles that of subepithelial fibroblasts; however, only EPDCs express the cardiac marker genes GATA4 and cardiac troponin T. After infection with an adenovirus vector encoding the transcription factor myocardin or after treatment with transforming growth factor-β1 or bone morphogenetic protein-2, EPDCs obtain characteristics of smooth muscle cells. Moreover, EPDCs can undergo osteogenesis but fail to form adipocytes or endothelial cells in vitro. Cultured epicardial cells from human adults recapitulate at least part of the differentiation potential of their embryonic counterparts and represent an excellent model system to explore the biological properties and therapeutic potential of these cells.

28 August 2013 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Open access
PDF file
SRSander F. Rodrigo
Sander F. Rodrigo
JRJan van Ramshorst
Jan van Ramshorst
GHGeorgette E. Hoogslag
Georgette E. Hoogslag
HBHelèn Boden
Helèn Boden
MVMatthijs A. Velders
Matthijs A. Velders
DADouwe E. Atsma
Douwe E. Atsma
In experimental studies, mesenchymal stem cell (MSC) transplantation in acute myocardial infarction (AMI) models has been associated with enhanced neovascularization and myogenesis. Clinical data however, are scarce. Therefore, the present study evaluates the safety and feasibility of intramyocardial MSC injection in nine patients, shortly after AMI during short-term and 5-year follow-up. Periprocedural safety analysis demonstrated one transient ischemic attack. No other adverse events related to MSC treatment were observed during 5-year follow-up. Clinical events were compared to a nonrandomized control group comprising 45 matched controls. A 5-year event-free survival after MSC-treatment was comparable to controls (89 vs. 91 %, P = 0.87). Echocardiographic imaging for evaluation of left ventricular function demonstrated improvements up to 5 years after MSC treatment. These findings were not significantly different when compared to controls. The present safety and feasibility study suggest that intramyocardial injection of MSC in patients shortly after AMI is feasible and safe up to 5-year follow-up.

19 November 2020 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
DFDaan L. de Frel
Daan L. de Frel
DADouwe E. Atsma
Douwe E. Atsma
HPHanno Pijl
Hanno Pijl
JSJacob C. Seidell
Jacob C. Seidell
PLPieter J. M. Leenen
Pieter J. M. Leenen
ERElisabeth F. C. van Rossum
Elisabeth F. C. van Rossum
Background: COVID-19 is a global challenge to healthcare. Obesity is common in patients with COVID-19 and seems to aggravate disease prognosis. In this review we explore the link between obesity, chronic disease, lifestyle factors and the immune system, and propose societal interventions to enhance global immunity.Search Strategy and Selection Criteria: We performed three literature searches using the keywords (1) coronavirus AND comorbidities, (2) comorbidities AND immune system, and (3) lifestyle factors AND immune system. Results were screened for relevance by the main author and a total of 215 articles were thoroughly analyzed.Results: The relationship between obesity and unfavorable COVID-19 prognosis is discussed in light of the impact of chronic disease and lifestyle on the immune system. Several modifiable lifestyle factors render us susceptible to viral infections. In this context, we make a case for fostering a healthy lifestyle on a global scale.Conclusions: Obesity, additional chronic disease and an unhealthy lifestyle interactively impair immune function and increase the risk of severe infectious disease. In adverse metabolic and endocrine conditions, the immune system is geared toward inflammation. Collective effort is needed to ameliorate modifiable risk factors for obesity and chronic disease on a global scale and increase resistance to viruses like SARS-CoV-2.

2 September 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ASAnna V Silven
Anna V Silven
APAnnelieke H J Petrus
Annelieke H J Petrus
MVMaría Villalobos-Quesada
María Villalobos-Quesada
EDEbru Dirikgil
Ebru Dirikgil
COCarlijn R Oerlemans
Carlijn R Oerlemans
YTY K Onno Teng
Y K Onno Teng
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

9 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ARArti A. Ramkisoensing
Arti A. Ramkisoensing
DPDaniël A. Pijnappels
Daniël A. Pijnappels
SASaïd F. A. Askar
Saïd F. A. Askar
RPRobert Passier
Robert Passier
JSJim Swildens
Jim Swildens
DADouwe E. Atsma
Douwe E. Atsma
Mesenchymal stem cells (MSCs) show unexplained differences in differentiation potential. In this study, differentiation of human (h) MSCs derived from embryonic, fetal and adult sources toward cardiomyocytes, endothelial and smooth muscle cells was investigated. Labeled hMSCs derived from embryonic stem cells (hESC-MSCs), fetal umbilical cord, bone marrow, amniotic membrane and adult bone marrow and adipose tissue were co-cultured with neonatal rat cardiomyocytes (nrCMCs) or cardiac fibroblasts (nrCFBs) for 10 days, and also cultured under angiogenic conditions. Cardiomyogenesis was assessed by human-specific immunocytological analysis, whole-cell current-clamp recordings, human-specific qRT-PCR and optical mapping. After co-culture with nrCMCs, significantly more hESC-MSCs than fetal hMSCs stained positive for α-actinin, whereas adult hMSCs stained negative. Furthermore, functional cardiomyogenic differentiation, based on action potential recordings, was shown to occur, but not in adult hMSCs. Of all sources, hESC-MSCs expressed most cardiac-specific genes. hESC-MSCs and fetal hMSCs contained significantly higher basal levels of connexin43 than adult hMSCs and co-culture with nrCMCs increased expression. After co-culture with nrCFBs, hESC-MSCs and fetal hMSCs did not express α-actinin and connexin43 expression was decreased. Conduction velocity (CV) in co-cultures of nrCMCs and hESC-MSCs was significantly higher than in co-cultures with fetal or adult hMSCs. In angiogenesis bioassays, only hESC-MSCs and fetal hMSCs were able to form capillary-like structures, which stained for smooth muscle and endothelial cell markers.Human embryonic and fetal MSCs differentiate toward three different cardiac lineages, in contrast to adult MSCs. Cardiomyogenesis is determined by stimuli from the cellular microenvironment, where connexin43 may play an important role.